Please provide your email address to receive an email when new articles are posted on . Food allergies are serious and potentially life-threatening conditions affecting more than 33 million Americans, ...
In February 2024, the US Food and Drug Administration (FDA) approved Xolair (omalizumab; Genentech, Inc), an anti-immunoglobulin E (IgE) antibody, for the treatment of IgE-mediated food allergies in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback